PHAXIAM Therapeutics S.A. Cash Flow Quality Index
PHAXIAM Therapeutics S.A. cash flow quality index. PHAXIAM Therapeutics S.A. (PHXM) has a Cash Flow Quality Index of -1.87x as of December 2022. Operating cash flow of €-11.10 Million is below net income of €5.93 Million, suggesting accrual-heavy earnings not yet converted to cash. See PHXM financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
PHAXIAM Therapeutics S.A. Cash Flow Quality Index by Year (None–None)
PHAXIAM Therapeutics S.A. cash flow quality index by year from None to None. Year-by-year earnings quality comparison for PHAXIAM Therapeutics S.A.. For the full cash flow conversion analysis, see PHAXIAM Therapeutics S.A. (PHXM) cash conversion ratio.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|